Immune cell boost may keep leukemia at bay after transplant
NCT ID NCT05015426
First seen Nov 14, 2025 · Last updated May 01, 2026 · Updated 18 times
Summary
This early-phase trial tests whether infusing specially grown donor immune cells (γδ T-cells) can help prevent acute myeloid leukemia from coming back after a stem cell transplant. About 20 adults at high risk of relapse will receive a single infusion of these cells. The main goals are to find the safest dose and see how well it controls the leukemia.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE MYELOID LEUKEMIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Moffitt Cancer Center
Tampa, Florida, 33612, United States
Conditions
Explore the condition pages connected to this study.